Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.55B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.19B |
| 3 |
iShares Silver Trust
SLV
|
+$1.03B |
| 4 |
Walmart Inc
WMT
|
+$862M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$850M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.99B |
| 2 |
Micron Technology
MU
|
+$1.09B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$772M |
| 4 |
Tesla
TSLA
|
+$700M |
| 5 |
Direxion Daily Semiconductor Bull 3X ETF
SOXL
|
+$639M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.77% |
| 2 | Healthcare | 1.08% |
| 3 | Consumer Discretionary | 1.03% |
| 4 | Financials | 0.94% |
| 5 | Communication Services | 0.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SHCO
9651
DELISTED
Soho House & Co
SHCO
| $205K | ﹤0.01% |
22,888
+2,961
| +15% | +$26.3K |
|
|
CAI
9652
PUT
Caris Life Sciences
CAI
$6.16B
| $205K | ﹤0.01% |
+7,600
| New | +$214K |
|
9653
ESS Tech
GWH
$20.4M
| $205K | ﹤0.01% |
109,012
+60,054
| +123% | +$191K |
|
9654
ArcelorMittal
MT
$55.7B
| $205K | ﹤0.01% |
4,497
-33,403
| -88% | -$1.37M |
|
|
CONI
9655
GraniteShares 2x Short COIN Daily ETF
CONI
$12.4M
| $205K | ﹤0.01% |
3,000
-9,010
| -75% | -$426K |
|
9656
PUT
XPEL
XPEL
$1.38B
| $205K | ﹤0.01% |
4,100
-4,100
| -50% | -$171K |
|
9657
CALL
ProShares Short Russell2000
RWM
$98.9M
| $205K | ﹤0.01% |
+12,500
| New | +$207K |
|
9658
CALL
Mitsubishi UFJ Financial
MUFG
$260B
| $205K | ﹤0.01% |
12,900
+2,000
| +18% | +$30.9K |
|
9659
Lifetime Brands
LCUT
$226M
| $205K | ﹤0.01% |
51,795
+41,191
| +388% | +$151K |
|
|
PMT
9660
CALL
PennyMac Mortgage Investment
PMT
$824M
| $205K | ﹤0.01% |
16,300
-44,500
| -73% | -$555K |
|
|
FSFG
9661
DELISTED
First Savings Financial Group
FSFG
| $205K | ﹤0.01% |
+6,420
| New | +$200K |
|
9662
Goldman Sachs Future Health Care Equity ETF
GDOC
$18.5M
| $204K | ﹤0.01% |
5,753
-4,394
| -43% | -$154K |
|
|
HFEQ
9663
Unlimited HFEQ Equity Long/Short ETF
HFEQ
$19.4M
| $204K | ﹤0.01% |
9,800
-2,921
| -23% | -$66.3K |
|
9664
UNIFI
UFI
$120M
| $204K | ﹤0.01% |
58,311
+46,336
| +387% | +$179K |
|
|
TVRD
9665
Tvardi Therapeutics
TVRD
$25.3M
| $204K | ﹤0.01% |
+47,444
| New | +$425K |
|
9666
BioXcel Therapeutics
BTAI
$36.7M
| $204K | ﹤0.01% |
+127,501
| New | +$263K |
|
9667
iBio
IBIO
$71M
| $204K | ﹤0.01% |
+105,700
| New | +$144K |
|
|
INV
9668
PUT
Innventure Inc
INV
$136M
| $204K | ﹤0.01% |
+48,800
| New | +$205K |
|
|
JUNM
9669
FT Vest U.S. Equity Max Buffer ETF - June
JUNM
$67.3M
| $204K | ﹤0.01% |
+5,957
| New | +$202K |
|
9670
CALL
Teradata
TDC
$2.57B
| $204K | ﹤0.01% |
+6,700
| New | +$175K |
|
9671
Lear
LEA
$8.32B
| $204K | ﹤0.01% |
1,779
-74,438
| -98% | -$7.95M |
|
|
MESO
9672
PUT
Mesoblast
MESO
$2.02B
| $204K | ﹤0.01% |
11,300
-23,900
| -68% | -$411K |
|
9673
Ecovyst
ECVT
$1.14B
| $204K | ﹤0.01% |
20,949
-82,410
| -80% | -$719K |
|
9674
Greenwich LifeSciences
GLSI
$247M
| $203K | ﹤0.01% |
+9,677
| New | +$102K |
|
9675
PUT
Arcutis Biotherapeutics
ARQT
$3.29B
| $203K | ﹤0.01% |
7,000
-7,100
| -50% | -$182K |
|
Similar funds
Jane Street's Q4 2025 Portfolio in Review
As of Q4 2025, Jane Street held 12,943 positions worth $662B, up 0.76% from $657B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Jane Street's Q4 2025 filing shows 2,363 new, 4,318 increased, 4,192 reduced and 1,998 closed positions. Its largest new stake was iShares MSCI India ETF: 4,400,850 shares worth $238M. The largest sale was NVIDIA, an estimated $1.99B.
By sector, the portfolio is most concentrated in Technology at 2.8% of assets, down from 3.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jane Street's largest Q4 2025 buy was iShares MSCI India ETF: 4,400,850 shares worth $238M.
- Jane Street added most to State Street SPDR S&P 500 ETF Trust in Q4 2025, an estimated $5.55B increase.
- Jane Street's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $1.99B.
- Jane Street fully exited Applied Digital in Q4 2025, selling an estimated $207M.
- Jane Street's ten largest holdings make up 34% of its $662B portfolio in Q4 2025.
- Jane Street opened 2,363 new positions and closed 1,998 in Q4 2025.
- Jane Street's portfolio value rose 0.76% quarter-over-quarter to $662B.
Based on Jane Street's 13F filing for Q4 2025, filed 12 Feb 2026.